UKHSA urges pilgrims to get meningitis vaccination

The UK Health Security Agency (UKHSA) is urging travellers to the Kingdom of Saudi Arabia (KSA) for Umrah and the upcoming Hajj pilgrimages to ensure they are vaccinated against meningococcal disease with the MenACWY vaccine, due to ongoing outbreaks of serogroup W (MenW) disease associated with travel to KSA.

UKHSA has confirmed 5 cases of MenW disease between February and March 2025 in people who had recently returned from KSA or in their close contacts in England and Wales.

Invasive meningococcal disease is rare but serious and is caused by meningococcal bacteria. Meningococcal meningitis (inflammation of the lining of the brain and spinal cord) and septicaemia (blood poisoning) are severe conditions that can kill or leave people with life-changing disabilities.

Those undertaking Hajj or Umrah, along with seasonal workers, are required to present a valid certificate of MenACWY vaccination issued between 10 days and 3 to 5 years before arrival, depending on the type of MenACWY vaccine previously received. The World Health Organization (WHO) and the National Travel Health Network and Centre (NaTHNaC) advise, however, that all travellers to KSA should consider receiving the quadrivalent meningococcal (MenACWY) vaccine, especially during the current MenW outbreak.